Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Goldman Sachs MarketBeta International Equity ETF
GSID
$1.13B
| $3.97M | ﹤0.01% |
88,633
+55,879
| +171% | +$2.72M |
|
4127
Costamare
CMRE
$1.77B
| $3.97M | ﹤0.01% |
328,303
-59,511
| -15% | -$827K |
|
4128
CALL
Teucrium Corn Fund
CORN
$171M
| $3.97M | ﹤0.01% |
157,700
+51,200
| +48% | +$1.46M |
|
4129
CALL
BioCryst Pharmaceuticals
BCRX
$2.49B
| $3.97M | ﹤0.01% |
374,900
-145,800
| -28% | -$1.5M |
|
4130
iShares GNMA Bond ETF
GNMA
$432M
| $3.97M | ﹤0.01% |
87,081
-5,858
| -6% | -$270K |
|
4131
Wabash National
WNC
$512M
| $3.96M | ﹤0.01% |
291,877
+81,061
| +38% | +$1.17M |
|
4132
Select Water Solutions
WTTR
$2.69B
| $3.96M | ﹤0.01% |
581,301
+240,727
| +71% | +$1.95M |
|
4133
CALL
HealthEquity
HQY
$8.76B
| $3.96M | ﹤0.01% |
64,500
-2,400
| -4% | -$154K |
|
4134
PUT
Tradeweb Markets
TW
$22.4B
| $3.96M | ﹤0.01% |
58,000
+30,600
| +112% | +$2.22M |
|
4135
PUT
AGCO
AGCO
$7.1B
| $3.96M | ﹤0.01% |
40,100
-22,500
| -36% | -$2.8M |
|
4136
PUT
Helmerich & Payne
HP
$4.42B
| $3.96M | ﹤0.01% |
91,900
-12,800
| -12% | -$595K |
|
4137
PUT
B&G Foods
BGS
$294M
| $3.95M | ﹤0.01% |
166,200
+42,300
| +34% | +$1.05M |
|
4138
CALL
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $3.95M | ﹤0.01% |
107,300
+61,400
| +134% | +$2.43M |
|
|
ANAC
4139
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
| $3.95M | ﹤0.01% |
402,365
-760,242
| -65% | -$7.45M |
|
4140
First Bancorp
FBNC
$2.74B
| $3.95M | ﹤0.01% |
113,101
+46,169
| +69% | +$1.72M |
|
4141
CALL
KeyCorp
KEY
$25B
| $3.95M | ﹤0.01% |
229,000
+24,400
| +12% | +$472K |
|
4142
CALL
Vanguard Morningstar Small-Cap ETF
VB
$83.6B
| $3.94M | ﹤0.01% |
22,400
-2,600
| -10% | -$502K |
|
4143
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $3.94M | ﹤0.01% |
20,915
-15,523
| -43% | -$3.19M |
|
|
ENER
4144
DELISTED
Accretion Acquisition Corp
ENER
| $3.94M | ﹤0.01% |
400,013
-436
| -0.1% | -$4.29K |
|
|
PAQC
4145
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
| $3.94M | ﹤0.01% |
399,811
+18
| +0% | +$177 |
|
4146
PUT
Nabors Industries
NBR
$1.39B
| $3.94M | ﹤0.01% |
29,400
+25,600
| +674% | +$4.01M |
|
4147
iShares Micro-Cap ETF
IWC
$1.52B
| $3.94M | ﹤0.01% |
37,849
+28,533
| +306% | +$3.29M |
|
4148
CALL
Leggett & Platt
LEG
$1.32B
| $3.94M | ﹤0.01% |
113,800
+15,400
| +16% | +$564K |
|
4149
Spectral AI
MDAI
$54.1M
| $3.93M | ﹤0.01% |
400,771
+2,543
| +0.6% | +$24.9K |
|
|
QDRO
4150
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
| $3.93M | ﹤0.01% |
400,000
| – | – |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.